Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'THYMIDINE LABELING INDEX' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 71 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Allred, DC; Mohsin, SK; Fuqua, SAW
      Histological and biological evolution of human premalignant breast disease

      ENDOCRINE-RELATED CANCER
    2. Chassevent, A; Jourdan, ML; Romain, S; Descotes, F; Colonna, M; Martin, PM; Bolla, M; Spyratos, F
      S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: A standardizedflow cytometric study

      CLINICAL CANCER RESEARCH
    3. Paradiso, A; Schittulli, F; Cellamare, G; Mangia, A; Marzullo, F; Lorusso, V; De Lena, M
      Randomized clinical trial of adjuvant fluorouracil, epirubicin, and cyclophosphamide chemotherapy for patients with fast-proliferating, node-negativebreast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    4. Daidone, MG; Costa, A; Silvestrini, R
      Cell proliferation markers in human solid tumors: Assessing their impact in clinical oncology

      METHODS IN CELL BIOLOGY, VOL 64
    5. Pronzato, P; Queirolo, P; Vecchio, S; Lionetto, R; Del Mastro, L; Venturini, M; Gardin, G; Alama, A; Sertoli, MR
      Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy

      ONCOLOGY
    6. Salihoglu, Y; Bilir, A; Aydiner, A; Erkan, M; Tuzlali, S; Eralp, Y
      Thymidine labeling index in epithelial ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
    7. Allred, DC; Mohsin, SK
      Biological features of premalignant disease in the human breast disease

      JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
    8. Barzanti, F; Dal Susino, M; Volpi, A; Amadori, D; Riccobon, A; Scarpi, E; Medri, L; Bernardi, L; Naldi, S; Aldi, M; Gaudio, M; Zoli, W
      Comparison between different cell kinetic variables in human breast cancer

      CELL PROLIFERATION
    9. Amadori, D; Nanni, O; Marangolo, M; Pacini, P; Ravaioli, A; Rossi, A; Gambi, A; Catalano, G; Perroni, D; Scarpi, E; Giunchi, DC; Tienghi, A; Becciolini, A; Volpi, A
      Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: A randomized multicenter study

      JOURNAL OF CLINICAL ONCOLOGY
    10. Volpi, A; Nanni, O; Vecci, AM; Naldi, S; Bernardi, L; Marri, L; Fedeli, SL; Serra, P; Amadori, D
      Feasibility of a cell kinetic-based adjuvant chemotherapy trial in axillary node-negative breast cancer

      TUMORI
    11. Mariani, L; Conti, L; Antenucci, A; Vercillo, M; Atlante, M; Gandolfo, GM
      Predictive value of cell kinetics in endometrial adenocarcinoma

      ANTICANCER RESEARCH
    12. Volpi, A; De Paola, F; Nanni, O; Granato, AM; Bajorko, P; Becciolini, A; Scarpi, E; Riccobon, A; Balzi, M; Amadori, D
      Prognostic significance of biologic markers in node-negative breast cancerpatients: a prospective study

      BREAST CANCER RESEARCH AND TREATMENT
    13. Daidone, MG; Luisi, A; Martelli, G; Benini, E; Veneroni, S; Tomasic, G; De Palo, G; Silvestrini, R
      Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women

      BRITISH JOURNAL OF CANCER
    14. Meyer, JS; Fahrner, M; Daniel, FC
      Pathology and behavior of small breast carcinomas

      SEMINARS IN DIAGNOSTIC PATHOLOGY
    15. Midulla, C; Cenci, M; de Iorio, P; Pisani, T; Bonaccorsi, A; de Marchis, L; Nofroni, I; Vecchione, A
      DNA ploidy and TLI in association with other prognostic parameters in breast cancer

      ANTICANCER RESEARCH
    16. Rudolph, P; MacGrogan, G; Bonichon, F; Frahm, SO; de Mascarel, I; Trojani, M; Durand, M; Avril, A; Coindre, JM; Parwaresch, R
      Prognostic significance of Ki-67 and topoisomerase II alpha expression in infiltrating ductal carcinoma of the breast - A multivariate analysis of 863 cases

      BREAST CANCER RESEARCH AND TREATMENT
    17. Imamura, H; Haga, S; Shimizu, T; Watanabe, O; Kajiwara, T; Aiba, M
      Prognostic significance of MIB1-determined proliferative activities in intraductal components and invasive foci associated with invasive ductal breast carcinoma

      BRITISH JOURNAL OF CANCER
    18. Ravaioli, A; Bagli, L; Zucchini, A; Monti, F
      Prognosis and prediction of response in breast cancer: the current role ofthe main biological markers

      CELL PROLIFERATION
    19. COLLECCHI P; BALDINI E; GIANNESSI P; NACCARATO AG; PASSONI A; GARDIN G; RONCELLA M; EVANGELISTA G; BEVILACQUA G; CONTE PF
      PRIMARY CHEMOTHERAPY IN LOCALLY ADVANCED BREAST-CANCER (LABC) - EFFECTS ON TUMOR PROLIFERATIVE ACTIVITY, BCL-2 EXPRESSION AND THE RELATIONSHIP BETWEEN TUMOR-REGRESSION AND BIOLOGICAL MARKERS

      European journal of cancer
    20. Bankfalvi, A; Schmitz, K; Mock, T; Kemper, M; Cubick, C; Bocker, W
      Relationship between AgNOR proteins, Ki-67 antigen, p53 immunophenotype and differentiation markers in archival breast carcinomas

      ANALYTICAL CELLULAR PATHOLOGY
    21. Page, DL; Jensen, RA; Simpson, JF
      Routinely available indicators of prognosis in breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    22. MONGKONSRITRAGOON W; LETENDRE L; QIAN JQ; LI CY
      NODULAR LESIONS OF MONOCYTIC COMPONENT IN MYELODYSPLASTIC SYNDROME

      AJCP. American journal of clinical pathology
    23. BENINI E; RAO S; DAIDONE MG; PILOTTI S; SILVESTRINI R
      IMMUNOREACTIVITY TO MIB-1 IN BREAST-CANCER - METHODOLOGICAL ASSESSMENT AND COMPARISON WITH OTHER PROLIFERATION, INDEXES

      Cell proliferation
    24. MOCHEN C; GIARDINI R; COSTA A; SILVESTRINI R
      MIB-1 AND S-PHASE CELL FRACTION PREDICT SURVIVAL IN NON-HODGKINS-LYMPHOMAS

      Cell proliferation
    25. RUDAS M; NEUMAYER R; GNANT MFX; MITTELBOCK M; JAKESZ R; REINER A
      P53 PROTEIN EXPRESSION, CELL-PROLIFERATION AND STEROID-HORMONE RECEPTORS IN DUCTAL AND LOBULAR IN-SITU CARCINOMAS OF THE BREAST

      European journal of cancer
    26. MATTURRI L; BIONDO B; LAVEZZI AM
      THYMIDINE LABELING INDEX IN COLORECTAL-CARCINOMA - RELATION TO CLINICOPATHOLOGICAL PARAMETERS AND TO MITOTIC INDEX

      Cancer detection and prevention
    27. MATTURRI L; BIONDO B; TAMPLENIZZA P; OTTAVIANI A; LAVEZZI AM
      DNA CONTENT AND THYMIDINE LABELING INDEX CORRELATE WITH PROGNOSIS IN SQUAMOUS-CELL CARCINOMA OF THE LARYNX

      Cancer detection and prevention
    28. JANSSEN T; PETEIN M; VANVELTHOVEN R; DEDECKER R; ASSENMACHER C; CORBUSIER A; PASTEELS JL; KISS R; SCHULMAN C
      COREGULATORY EFFECTS OF EPIDERMAL GROWTH-FACTOR, DIHYDROTESTOSTERONE,AND PROLACTIN ON BENIGN HUMAN PROSTATIC HYPERPLASIA TISSUE-CULTURE PROLIFERATION

      The Prostate
    29. GUINEBRETIERE JM; SABOURIN JC
      KI-67, A MARKER OF PROLIFERATION

      Annales de pathologie
    30. AMADORI D; VOLPI A; MALTONI R; NANNI O; AMADUCCI L; AMADORI A; GIUNCHI DC; VIO A; SARAGONI A; SILVESTRINI R
      CELL-PROLIFERATION AS A PREDICTOR OF RESPONSE TO CHEMOTHERAPY IN METASTATIC BREAST-CANCER - A PROSPECTIVE-STUDY

      Breast cancer research and treatment
    31. DEFRANCESCHI L; CONTI L; MORO L; FRANCAVILLA V; VALENTE F; CASOLE PM; GRASSI A; CASALE V; GANDOLFO GM
      STUDY OF CELL-KINETICS IN THE NORMAL COLORECTAL MUCOSA OF SUBJECTS ATRISK OF DEVELOPING COLORECTAL-CARCINOMA

      Oncology
    32. SILVESTRINI R; DAIDONE MG; LUISI A; MASTORE M; LEUTNER M; SALVADORI B
      CELL-PROLIFERATION IN 3.800 NODE-NEGATIVE BREAST CANCERS - CONSISTENCY OVER TIME OF BIOLOGICAL AND CLINICAL INFORMATION PROVIDED BY H-3 THYMIDINE LABELING INDEX

      International journal of cancer
    33. KENNEDY MM; LAMB D; KING G; KERR KM
      CELL-PROLIFERATION, CELL LOSS AND EXPRESSION OF BCL-2 AND P53 IN HUMAN PULMONARY NEOPLASMS

      British Journal of Cancer
    34. BROWN RW; ALLRED DC; CLARK GM; OSBORNE CK; HILSENBECK SG
      PROGNOSTIC VALUE OF KI-67 COMPARED TO S-PHASE FRACTION IN AXILLARY NODE-NEGATIVE BREAST-CANCER

      Clinical cancer research
    35. COLLAN YUI; KUOPIO T; BAAK JPA; BECKER R; BOGOMOLETZ WV; DEVERELL M; VANDIEST P; VANGALEN C; GILCHRIST K; JAVED A; KOSMA VM; KUJARI H; LUZI P; MARIUZZI GM; MATZE E; MONTIRONI R; SCARPELLI M; SIERRA D; SISTI S; TOIKKANEN S; TOSI P; WHIMSTER WF; WISSE E
      STANDARDIZED MITOTIC COUNTS IN BREAST-CANCER EVALUATION OF THE METHOD

      Pathology research and practice
    36. WILLNOW U; DUMON K; GODEHARDT E
      EFFECT OF HYPERTHERMIA 42.5-DEGREES-C 120 MIN ON 3H-THYMIDINE INCORPORATION IN DIFFERENT TISSUE-COMPONENTS OF WILMS-TUMORS - AN IN-VITRO STUDY

      Klinische Padiatrie
    37. VONKLEIST S
      PROGNOSTIC FACTORS IN BREAST-CANCER - THEORETICAL AND CLINICAL ASPECTS (REVIEW)

      Anticancer research
    38. BONETTI A; ZANINELLI M; RODELLA S; MOLINO A; SPEROTTO L; PIUBELLO Q; BONETTI F; NORTILLI R; TURAZZA M; CETTO GL
      TUMOR PROLIFERATIVE ACTIVITY AND RESPONSE TO FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CARCINOMA

      Breast cancer research and treatment
    39. PIERGA JY; LEROYER A; VIEHL P; MOSSERI V; CHEVILLARD S; MAGDELENAT H
      LONG-TERM PROGNOSTIC VALUE OF GROWTH FRACTION DETERMINATION BY KI-67 IMMUNOSTAINING IN PRIMARY OPERABLE BREAST-CANCER

      Breast cancer research and treatment
    40. GILLILAND R; WILLIAMSON KE; WILSON RH; ANDERSON NH; HAMILTON PW
      COLORECTAL CELL-KINETICS

      British Journal of Surgery
    41. STANTON PD; COOKE TG; FORSTER G; SMITH D; GOING JJ
      CELL-KINETICS IN-VIVO OF HUMAN BREAST-CANCER

      British Journal of Surgery
    42. COSTA A; SILVESTRINI R; MOCHEN C; LEQUAGLIE C; BORACCHI P; FARANDA A; VESSECCHIA G; RAVASI G
      P53 EXPRESSION, DNA-PLOIDY AND S-PHASE CELL FRACTION IN OPERABLE LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER

      British Journal of Cancer
    43. EKRAMULLAH SM; SAITOH Y; ARITA N; OHNISHI T; HAYAKAWA T
      THE CORRELATION OF KI-67 STAINING INDEXES WITH TUMOR DOUBLING TIMES IN REGROWING NONFUNCTIONING PITUITARY-ADENOMAS

      Acta neurochirurgica
    44. CASCINU S; DELFERRO E; GRIANTI C; FOGLIETTI GP; OLIVIERI Q; BARTOLUCCI M; SABA V; LUNGAROTTI F; CATALANO G
      HYPERPROLIFERATIVE STATE OF THE EPYTHELIUM IN THE REMAINING COLORECTAL MUCOSA AFTER SURGERY FOR CANCER OF THE LARGE-BOWEL - ITS IMPLICATIONS IN THE PREDICTION OF ADENOMATOUS POLYPS RECURRENCE

      GI cancer
    45. PARADISO A; MANGIA A; BARLETTA A; FUSILLI S; MARZULLO F; SCHITTULLI F; DELENA M
      HETEROGENEITY OF INTRATUMOR PROLIFERATIVE ACTIVITY IN PRIMARY BREAST-CANCER - BIOLOGICAL AND CLINICAL ASPECTS

      European journal of cancer
    46. LI TJ; BROWNE RM; MATTHEWS JB
      EPITHELIAL-CELL PROLIFERATION IN ODONTOGENIC KERATOCYSTS - A COMPARATIVE IMMUNOCYTOCHEMICAL STUDY OF KI67 IN SIMPLE, RECURRENT AND BASAL-CELL NEVUS SYNDROME (BCNS)-ASSOCIATED LESIONS

      Journal of oral pathology & medicine
    47. NEDERGAARD L; HAERSLEV T; JACOBSEN GK
      IMMUNOHISTOCHEMICAL STUDY OF ESTROGEN-RECEPTORS IN PRIMARY BREAST CARCINOMAS AND THEIR LYMPH-NODE METASTASES INCLUDING COMPARISON OF 2 MONOCLONAL-ANTIBODIES

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    48. LI TJ; BROWNE RM; MATTHEWS JB
      EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AND KI-67 IN UNICYSTIC AMELOBLASTOMA

      Histopathology
    49. SYMMANS WF; LIU JG; KNOWLES DM; INGHIRAMI G
      BREAST-CANCER HETEROGENEITY - EVALUATION OF CLONALITY IN PRIMARY AND METASTATIC LESIONS

      Human pathology
    50. DAIDONE MG; SILVESTRINI R; LUISI A; MASTORE M; BENINI E; VENERONI S; BRAMBILLA C; FERRARI L; GRECO M; ANDREOLA S; VERONESI U
      CHANGES IN BIOLOGICAL MARKERS AFTER PRIMARY CHEMOTHERAPY FOR BREAST CANCERS

      International journal of cancer
    51. STEEB CB; TRAHAIR JF; READ LC
      ADMINISTRATION OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) PEPTIDES FOR 3DAYS STIMULATES PROLIFERATION OF THE SMALL-INTESTINAL EPITHELIUM IN RATS

      Gut
    52. HOFMOCKEL G; TSATALPAS P; MULLER H; DAMMRICH J; POOT M; MAURERSCHULTZE B; MULLERHERMELINK HK; FROHMULLER HGW; BASSUKAS ID
      SIGNIFICANCE OF CONVENTIONAL AND NEW PROGNOSTIC FACTORS FOR LOCALLY CONFINED RENAL-CELL CARCINOMA

      Cancer
    53. HOFMOCKEL G; BASSUKAS ID; TSATALPAS P; MULLER H; RIESS S; DAMMRICH J; BOOT M; MAURERSCHULTZE B; FROHMULLER H
      SIGNIFICANCE OF DIFFERENT PROGNOSTIC FACT ORS FOR LOCALLY CONFINED RENAL-CELL CARCINOMAS

      Aktuelle Urologie
    54. CASCINU S; DELFERRO E; LIGI M; SANI F; GRIANTI C; CATALANO G
      CORRELATION AMONG [H-3] THYMIDINE, FLOW-CYTOMETRY AND PROLIFERATING CELL NUCLEAR ANTIGEN INDEXES IN COLORECTAL TUMORS

      Oncology Reports
    55. FARANDA A; COSTA A; SILVESTRINI R; QUAGLIUOLO V; GENNARI L
      S-PHASE CELL FRACTION IN THE PROGNOSIS OF DUKES STAGE-D COLORECTAL-CARCINOMA

      Cell proliferation
    56. SILVESTRINI R
      CELL-KINETICS - PROGNOSTIC AND THERAPEUTIC IMPLICATIONS IN HUMAN TUMORS

      Cell proliferation
    57. ZAGHLOUL MS; DORIE MJ; KALLMAN RF
      INTERLEUKIN-1 INCREASES THYMIDINE LABELING INDEX OF NORMAL-TISSUES OFMICE BUT NOT THE TUMOR

      International journal of radiation oncology, biology, physics
    58. BARBIERI F; PARODI G; MASSA T; CAGNOLI M; BARBI G; IMPERIALE A; ALAMA A
      FEASIBILITY OF THYMIDINE LABELING INDEX ON FINE-NEEDLE ASPIRATES FROMBREAST-CANCER - COMPARISON WITH SURGICAL SAMPLES

      Anticancer research
    59. SILVESTRINI R; LUISI A; DAIDONE MG; COSTA A; VALENTINIS B; ZUPI G; DAGNANO I; GEIDO E; GIARETTI W; PEPE S; RUGGIERO A; RUSSO A; BAZAN V; FACCHINI A; LALLI E; MAZZINI G; UNGARI S; RIBA S
      QUALITY-CONTROL FOR EVALUATION OF THE S-PHASE FRACTION BY FLOW-CYTOMETRY - A MULTICENTRIC STUDY

      Cytometry
    60. GARDIN G; ALAMA A; ROSSO R; CAMPORA E; REPETTO L; PRONZATO P; MERLINI L; NASO C; CAMORIANO A; MEAZZA R; BARBIERI F; BALDINI E; GIANNESSI PG; CONTE PF
      RELATIONSHIP OF VARIATIONS IN TUMOR-CELL KINETICS INDUCED BY PRIMARY CHEMOTHERAPY TO TUMOR-REGRESSION AND PROGNOSIS IN LOCALLY ADVANCED BREAST-CANCER

      Breast cancer research and treatment
    61. MUSS HB; THOR AD; BERRY DA; KUTE T; LIU ET; KOERNER F; CIRRINCIONE CT; BUDMAN DR; WOOD WC; BARCOS M; HENDERSON IC
      C-ERBB-2 EXPRESSION AND RESPONSE TO ADJUVANT THERAPY IN WOMEN WITH NODE-POSITIVE EARLY BREAST-CANCER

      The New England journal of medicine
    62. MEYER JS; PROVINCE MA
      S-PHASE FRACTION AND NUCLEAR SIZE IN LONG-TERM PROGNOSIS OF PATIENTS WITH BREAST-CANCER

      Cancer
    63. WARNAKULASURIYA KAAS; JOHNSON NW
      COMPARISON OF ISOTOPIC AND IMMUNOHISTOCHEMICAL METHODS OF STUDYING EPITHELIAL-CELL PROLIFERATION IN HAMSTER TONGUE

      Cell proliferation
    64. SILVESTRINI R
      PROLIFERATION MARKERS IN BREAST-CANCER

      European journal of cancer
    65. GAGLIA P; BERNARDI A; VENESIO T; CALDAROLA B; LAURO D; CAPPA APM; CALDERINI P; LISCIA DS
      CELL-PROLIFERATION OF BREAST-CANCER EVALUATED BY ANTI-BRDU AND ANTI-KI-67 ANTIBODIES - ITS PROGNOSTIC VALUE ON SHORT-TERM RECURRENCES

      European journal of cancer
    66. GNANT MFX; BLIJHAM GH; REINER A; SCHEMPER M; REYNDERS M; SCHUTTE B; VANASCHE C; STEGER G; JAKESZ R
      ANEUPLOIDY FRACTION BUT NOT DNA INDEX IS IMPORTANT FOR THE PROGNOSIS OF PATIENTS WITH STAGE-I AND STAGE-II BREAST-CANCER - 10-YEAR RESULTS

      Annals of oncology
    67. SILVESTRINI R; DAIDONE MG; MASTORE M; DIFRONZO G; CORADINI D; BORACCHI P; SQUICCIARINI P; SALVADORI B; VERONESI U
      CELL-KINETICS AS A PREDICTIVE FACTOR IN NODE-POSITIVE BREAST-CANCER TREATED WITH ADJUVANT HORMONE-THERAPY

      Journal of clinical oncology
    68. RITTER MA
      NEW APPROACHES TO CELL-KINETICS IN HUMAN TUMORS

      Current problems in cancer
    69. SILVESTRINI R; BENINI E; DAIDONE MG; VENERONI S; BORACCHI P; CAPPELLETTI V; DIFRONZO G; VERONESI U
      P53 AS AN INDEPENDENT PROGNOSTIC MARKER IN LYMPH NODE-NEGATIVE BREAST-CANCER PATIENTS

      Journal of the National Cancer Institute
    70. QUINN CM; WRIGHT NA
      THE USEFULNESS OF CLINICAL MEASUREMENTS OF CELL-PROLIFERATION IN GYNECOLOGICAL CANCER

      International journal of gynecological pathology
    71. FERNO M; BALDETORP B; EWERS SB; IDVALL I; OLSSON H; SIGURDSSON H; KILLANDER D
      ONE OR MULTIPLE SAMPLINGS FOR FLOW CYTOMETRIC DNA ANALYSES IN BREAST-CANCER PROGNOSTIC IMPLICATIONS

      Cytometry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 01:03:00